MAX MAGNESIUM Trademark

Trademark Overview


On Tuesday, September 9, 2008, a trademark application was filed for MAX MAGNESIUM with the United States Patent and Trademark Office. The USPTO has given the MAX MAGNESIUM trademark a serial number of 77566043. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 14, 2009. The MAX MAGNESIUM trademark is filed in the Pharmaceutical Products category with the following description:

Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of magnesium deficiency; Pharmaceutical preparations for the treatment of magnesium deficiency; Pharmaceutical ...
max magnesium

General Information


Serial Number77566043
Word MarkMAX MAGNESIUM
Filing DateTuesday, September 9, 2008
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, July 14, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnalgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of magnesium deficiency; Pharmaceutical preparations for the treatment of magnesium deficiency; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 12, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressHamburg, NY 14075

Trademark Events


Event DateEvent Description
Tuesday, July 14, 2009ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, July 14, 2009ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, December 16, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 16, 2008NON-FINAL ACTION E-MAILED
Tuesday, December 16, 2008NON-FINAL ACTION WRITTEN
Thursday, December 11, 2008ASSIGNED TO EXAMINER
Friday, September 12, 2008NEW APPLICATION ENTERED IN TRAM